tiprankstipranks
ASKA Pharmaceutical Holdings Co., Ltd. (JP:4886)
:4886
Japanese Market
4886
ASKA Pharmaceutical Holdings Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4886 full AI Analyst Report?

ASKA Pharmaceutical Holdings Co., Ltd. (4886) Financial Statements

0 Followers

ASKA Pharmaceutical Holdings Co., Ltd. Financial Overview

ASKA Pharmaceutical Holdings Co., Ltd.'s market cap is currently ¥79.70B. The company's EPS TTM is ¥178.85; its P/E ratio is 12.35; and it has a dividend yield of 2.52%. ASKA Pharmaceutical Holdings Co., Ltd. is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 71.13B¥ 64.14B¥ 62.84B¥ 60.46B¥ 56.61B
Gross Profit¥ 34.15B¥ 31.34B¥ 30.66B¥ 28.59B¥ 26.35B
Operating Income¥ 5.83B¥ 5.33B¥ 6.50B¥ 5.11B¥ 4.80B
EBITDA¥ 5.83B¥ 7.58B¥ 9.16B¥ 8.24B¥ 7.68B
Net Income¥ 5.42B¥ 5.10B¥ 7.54B¥ 4.24B¥ 4.29B
Balance Sheet
Cash & Short-Term Investments¥ 11.02B¥ 11.16B¥ 17.24B¥ 17.91B¥ 17.10B
Total Assets¥ 112.01B¥ 103.25B¥ 93.31B¥ 87.14B¥ 83.30B
Total Debt¥ 3.27B¥ 10.90B¥ 9.48B¥ 12.62B¥ 14.05B
Net Debt¥ -6.86B¥ 299.00M¥ -4.25B¥ -1.88B¥ 1.94B
Total Liabilities¥ 35.56B¥ 34.06B¥ 31.38B¥ 32.60B¥ 34.40B
Stockholders' Equity¥ 69.99B¥ 65.31B¥ 61.93B¥ 54.53B¥ 48.89B
Cash Flow
Free Cash Flow¥ 3.75B¥ -475.00M¥ 166.00M¥ 2.89B¥ 2.26B
Operating Cash Flow¥ 6.30B¥ 2.48B¥ 1.49B¥ 3.35B¥ 2.84B
Investing Cash Flow¥ -5.75B¥ -6.12B¥ 1.71B¥ -1.13B¥ 6.74B
Financing Cash Flow¥ -818.00M¥ -2.96B¥ -3.94B¥ -1.82B¥ -3.00B
Currency in JPY

ASKA Pharmaceutical Holdings Co., Ltd. Earnings and Revenue History

Income Statement >

ASKA Pharmaceutical Holdings Co., Ltd. Debt to Assets

Balance Sheet >

ASKA Pharmaceutical Holdings Co., Ltd. Cash Flow

Cash Flow >

ASKA Pharmaceutical Holdings Co., Ltd. Forecast EPS vs Actual EPS

Earnings >